The retrospective study of the incidence of premalignant stage of plasma cell disorders in patients who performed monoclonal protein testing
- Conditions
- premalignant stage of plasma cell disorders in patientspremalignant stageplasma cell disordersincidencemonoclonal protein testing
- Registration Number
- TCTR20240419005
- Lead Sponsor
- Mahidol University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
1. Patients who tested monoclonal protein using one of three methods: serum protein electrophoresis, immunofixation, serum free light chain in 2011 - 2021
2. Patients must not have been diagnosed with multiple myeloma or AL amyloidosis according to the diagnostic criteria of International myeloma working group 2014
Exclusion Criteria
1. insufficient data needed for analysis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of premalignant stage of plasma cell disorders patients at the end of year review from hospital medical record
- Secondary Outcome Measures
Name Time Method Percentage of premalignant stage of plasma cell disorders patients at the end of year calculate from primary outcome